Using 2019 dollars, the study said annualized end-of-life came to about $105,500 per patient. The report also found annualized treatment for prostate cancer came in around $71,300 per patient, while treatment for acute myeloid leukemia hit $239,400 per patient.

The researches estimated that the 2015 cost for medical care related to cancer was $165 billion, while prescription drugs added another $18 billion. Those costs are expected to increase to $221 billion for medical care and $25 billion for prescription drugs by 2030.

The report notes that the number of people diagnosed with cancer increases with age, and that an aging population and increased number of cancer survivors will contribute to the increased cost.

"Patient-provider discussions about treatment options should include not only expected survival, quality of life implications, and potential adverse events, but also expected costs of care for different treatments," said study author Robin Yabroff, senior scientific director of health services research at the American Cancer Society. "For patients with cancer who are working, these discussions should address how treatment affects the ability to work, especially if the patient's health insurance coverage is through their employer."

Read more: 

• Cancer takes a $94 billion economic toll
• Millennials face greater risk of obesity-related cancer than Boomers
• Cancer tops list of high-cost insurance claims for self-insured employers